Bridgitte Shen Lee, Alcon (C), Essilor (C), Eyevance (C), Guardian Health Sciences (F), Johnson & Johnson Vision (C), Johnson & Johnson Vision (R), Ocusoft (C), Pharmaceuticals (C), Shire (C), Shire (R), Sun Pharmaceuticals (C);
Rajan Malhotra, Abbott (C), Abbott (F), Alcon (C), Alcon (F), Allergan (C), Allergan (F), Bausch & Lomb (C), Bausch & Lomb (F), BioD (C), BioD (F), InSite Vision (C), InSite Vision (F), Katena Products (C), Katena Products (F), Nicox (C), Nicox (F), Oasis Medical (C), Oasis Medical (F), Shire (C), Shire (F), TearScience (C), TearScience (F);
Kenneth Sall, Aerie (F), Allergan (F), Allysta Pharmaceuticals (F), Cloudbreak (F), Cloudbreak (C), Inotek Pharma (F), Kala Pharmaceuticals (F), Kala Pharmaceuticals (C), La Roche (F), Novaliq (F), Ocular Therapuetix (F), Santen (F), Sun Pharmaceuticals (F), Sun Pharmaceuticals (C), TearSolutions (F), Topcon (F), Valeant (F);
Abayomi Ogundele, Sun Pharmaceutical, Inc. (E);
James Peace, None